Targeting the RAS/MAPK Pathway in Neurofibromatosis Type 1 and Plexiform Neurofibromas

Bruce R. Korf, MD, PhD, Michael J. Fisher, MD, and Roger J. Packer, MD discuss neurofibromatosis in this CME/MOC/NCPD/CPE activity titled "Targeting the RAS/MAPK Pathway in Neurofibromatosis Type 1 and Plexiform Neurofibromas: Improving Patient Outcomes With an Innovative Therapeutic Approach." For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/CPE information, and to apply for credit, please visit us at PeerView.com/QAD865. CME/MOC/NCPD/CPE credit will be available until December 17, 2021.